Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using…

Our study on 275 patients found genetic variants in 29.8% with malignancy and 28.6% with a cancer-prone family history. BRCA1/BRCA2 mutations were most common, stressing the need for genetic counseling and testing. https://t.co/ddAp7pFING